CISXF yields 1.54% · JNJ yields 2.13%● Live data
📍 CISXF pulled ahead of the other in Year 1
Combined, CISXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CISXF + JNJ for your $10,000?
China Steel Corporation manufactures and sells steel products in Taiwan, Vietnam, Malaysia, China, India, and internationally. It offers steel plates primarily for use in construction structures, shipbuilding, bridge beams, oil country tabular goods, machine structures, pressure vessels, and in climate/corrosion-resistant steel plates; steel bars and wire rods for use in general and machine structures, cold forging, hot forging, hard drawn steel wires, and welding electrodes; and hot-rolled coils and sheets that are used in automobile chassis, bridge beams, construction, road guardrails, steel pipe, pressure vessels, and landscaping. The company also provides cold-rolled coils for use in automobile stamping parts and home electronics products; parts requiring high-level forming, such as automobile and scooter components; a variety of PSE and structural reinforcement parts; and products requiring surface coating treatment, such as painting, electroplating, and the application of adhesive surfaces. In addition, it offers mechanical, communications, and electrical engineering services; and generates solar power. The company was incorporated in 1971 and is headquartered in Kaohsiung, Taiwan.
Full CISXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.